inventivecap.com

What It Is

Inventive Capital Partners (ICP) is an IP-focused asset management firm based in Toronto, Canada. It is not positioned as a payment service provider; instead, it invests in and arranges financing around intellectual property, invention rights, patent royalties, patent applications, know-how, trademarks, and related cash flows. According to its website, its core objective is to provide liquidity and financial solutions for IP assets in innovation-intensive industries.

Core Capabilities and Service Scope

In terms of service offerings, ICP mainly provides patent royalty/cash-flow acquisitions, IP structured finance solutions, financial sponsor roles, transaction services, fund management services, operational monitoring, and specialized patent valuation services. Its market approach includes primary or secondary LP interests, acquisition financing, M&A support, receivables arrangements based on contractual payment obligations, collateralized loan obligations, and converting future cash flows into upfront lump-sum cash or loans.

On the risk management side, the website provides relatively substantial detail: ICP emphasizes portfolio construction, industry allocation, risk-return profiles, exit potential, diversification, counterparty risk, litigation proceedings, patent quality assessment, valuation, and market analysis. Its team claims extensive experience in IP investing and has reportedly participated in investments involving IP assets in life sciences, music, film, pharmaceuticals, and other sectors.

Pricing, Compliance, and Payment Features

The website does not disclose management fees, performance fees, financing rates, transaction fees, minimum investment amounts, or settlement cycles. It also does not describe any payment methods, acquiring, clearing, or merchant settlement capabilities. Therefore, from a payments/fintech perspective, it should not be categorized as a payment gateway, e-wallet, or cross-border collection tool. On compliance, the site only mentions fund management responsibilities such as regulatory and tax reporting and compliance monitoring, but it does not disclose specific financial licenses, registration numbers, or regulators. These would need to be verified separately during due diligence.

Pros and Cons

Its strengths are its niche positioning and focus on industrial IP cash flows, making it relevant for companies and institutions with patent portfolios, royalty income, or a need to monetize intellectual property. Its structures also appear flexible, with an emphasis on non-competitive sources of capital and long-term financing relationships. The drawbacks are that the public information appears dated—the page copyright remains at 2014—and there is a lack of recent fund information, case studies, performance data, and regulatory disclosures. For SMEs or ordinary investors, the entry requirements, process, and costs are all opaque.

Best Fit and Access from China

ICP is better suited to manufacturers, technology companies, universities, research institutions, inventors, and institutional investors seeking exposure to IP assets or monetization of intellectual property. It is not suitable for users who need online payment acceptance, cross-border payment APIs, or merchant settlement. The website does not provide information about access from China, so network connectivity is unknown. Users looking for payment-related alternatives should consider Stripe, Adyen, Airwallex, PingPong, and similar providers; those interested in IP finance may look at DRI Capital, Royalty Pharma, or specialist intellectual property financing advisors.